The European Medicines Agency’s Committee for Medicinal Products for Human Use has granted a positive opinion for the use of Veklury (remdesivir) in COVID-19 patients with severe renal impairment, including those undergoing dialysis. This decision, subject to review by the European Commission (EC), could make remdesivir the first authorised antiviral ...